LEP and obesity due to melanocortin 4 receptor deficiency: Since hyperleptinemia in obesity is associated with impaired body weight regulation, energy homeostasis, and glucose intolerance [61], the decrease in leptin levels may further support the metabolic benefits of myricitrin.